Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases
This study is currently recruiting participants.
Verified March 2013 by Guangzhou Medical University
Sponsor:
Guangzhou Medical University
Information provided by (Responsible Party):
Haihong Yang, MD, Pricipal investigator, Guangzhou Medical University
ClinicalTrials.gov Identifier:
NCT01578668
First received: April 11, 2012
Last updated: March 14, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 2017 |
| Estimated Primary Completion Date: | January 2015 (Final data collection date for primary outcome measure) |